These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 24922480)
1. Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model. Dodd KA; McElroy AK; Jones TL; Zaki SR; Nichol ST; Spiropoulou CF PLoS Negl Trop Dis; 2014 Jun; 8(6):e2874. PubMed ID: 24922480 [TBL] [Abstract][Full Text] [Related]
2. Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses. Dodd KA; McElroy AK; Jones ME; Nichol ST; Spiropoulou CF J Virol; 2013 Jun; 87(11):6161-71. PubMed ID: 23536675 [TBL] [Abstract][Full Text] [Related]
3. Identification and Characterization of Rift Valley Fever Virus-Specific T Cells Reveals a Dependence on CD40/CD40L Interactions for Prevention of Encephalitis. Barbeau DJ; Cartwright HN; Harmon JR; Spengler JR; Spiropoulou CF; Sidney J; Sette A; McElroy AK J Virol; 2021 Nov; 95(23):e0150621. PubMed ID: 34495703 [TBL] [Abstract][Full Text] [Related]
4. CD4 T Cells, CD8 T Cells, and Monocytes Coordinate To Prevent Rift Valley Fever Virus Encephalitis. Harmon JR; Spengler JR; Coleman-McCray JD; Nichol ST; Spiropoulou CF; McElroy AK J Virol; 2018 Dec; 92(24):. PubMed ID: 30258000 [TBL] [Abstract][Full Text] [Related]
5. Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse. Gray KK; Worthy MN; Juelich TL; Agar SL; Poussard A; Ragland D; Freiberg AN; Holbrook MR PLoS Negl Trop Dis; 2012; 6(2):e1529. PubMed ID: 22389738 [TBL] [Abstract][Full Text] [Related]
6. Neutrophil and macrophage influx into the central nervous system are inflammatory components of lethal Rift Valley fever encephalitis in rats. Albe JR; Boyles DA; Walters AW; Kujawa MR; McMillen CM; Reed DS; Hartman AL PLoS Pathog; 2019 Jun; 15(6):e1007833. PubMed ID: 31220182 [TBL] [Abstract][Full Text] [Related]
7. Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis. Wonderlich ER; Caroline AL; McMillen CM; Walters AW; Reed DS; Barratt-Boyes SM; Hartman AL J Virol; 2018 Feb; 92(3):. PubMed ID: 29118127 [TBL] [Abstract][Full Text] [Related]
8. Development of Rift valley fever encephalitis in rats is mediated by early infection of olfactory epithelium and neuroinvasion across the cribriform plate. Boyles DA; Schwarz MM; Albe JR; McMillen CM; O'Malley KJ; Reed DS; Hartman AL J Gen Virol; 2021 Feb; 102(2):. PubMed ID: 33231535 [TBL] [Abstract][Full Text] [Related]
9. Limiting viral replication in hepatocytes alters Rift Valley fever virus disease manifestations. Xu L; Paine AC; Barbeau DJ; Alencastro F; Duncan AW; McElroy AK J Virol; 2023 Sep; 97(9):e0085323. PubMed ID: 37695055 [TBL] [Abstract][Full Text] [Related]
10. Rift Valley Fever Virus Encephalitis: Viral and Host Determinants of Pathogenesis. Wilson LR; McElroy AK Annu Rev Virol; 2024 Sep; 11(1):309-325. PubMed ID: 38635867 [TBL] [Abstract][Full Text] [Related]
11. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection. López-Gil E; Lorenzo G; Hevia E; Borrego B; Eiden M; Groschup M; Gilbert SC; Brun A PLoS Negl Trop Dis; 2013; 7(7):e2309. PubMed ID: 23875044 [TBL] [Abstract][Full Text] [Related]
12. Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats. Walters AW; Kujawa MR; Albe JR; Reed DS; Klimstra WB; Hartman AL Virology; 2019 Jan; 526():173-179. PubMed ID: 30396029 [TBL] [Abstract][Full Text] [Related]
13. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates. Smith DR; Johnston SC; Piper A; Botto M; Donnelly G; Shamblin J; Albariño CG; Hensley LE; Schmaljohn C; Nichol ST; Bird BH PLoS Negl Trop Dis; 2018 May; 12(5):e0006474. PubMed ID: 29742102 [TBL] [Abstract][Full Text] [Related]
14. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates. Terasaki K; Tercero BR; Makino S Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573 [TBL] [Abstract][Full Text] [Related]
15. Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice. Zhang S; Hao M; Feng N; Jin H; Yan F; Chi H; Wang H; Han Q; Wang J; Wong G; Liu B; Wu J; Bi Y; Wang T; Sun W; Gao Y; Yang S; Zhao Y; Xia X Viruses; 2019 Oct; 11(10):. PubMed ID: 31597372 [TBL] [Abstract][Full Text] [Related]
16. Isotype-Specific Fc Effector Functions Enhance Antibody-Mediated Rift Valley Fever Virus Protection Cartwright HN; Barbeau DJ; McElroy AK mSphere; 2021 Oct; 6(5):e0055621. PubMed ID: 34494884 [TBL] [Abstract][Full Text] [Related]
18. Rift Valley Fever Virus Infection Causes Acute Encephalitis in the Ferret. Barbeau DJ; Albe JR; Nambulli S; Tilston-Lunel NL; Hartman AL; Lakdawala SS; Klein E; Duprex WP; McElroy AK mSphere; 2020 Oct; 5(5):. PubMed ID: 33115835 [TBL] [Abstract][Full Text] [Related]
19. The NSs Protein Encoded by the Virulent Strain of Rift Valley Fever Virus Targets the Expression of Abl2 and the Actin Cytoskeleton of the Host, Affecting Cell Mobility, Cell Shape, and Cell-Cell Adhesion. Bamia A; Marcato V; Boissière M; Mansuroglu Z; Tamietti C; Romani M; Simon D; Tian G; Niedergang F; Panthier JJ; Flamand M; Souès S; Bonnefoy E J Virol; 2020 Dec; 95(1):. PubMed ID: 33087469 [TBL] [Abstract][Full Text] [Related]
20. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment. Scharton D; Bailey KW; Vest Z; Westover JB; Kumaki Y; Van Wettere A; Furuta Y; Gowen BB Antiviral Res; 2014 Apr; 104():84-92. PubMed ID: 24486952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]